Amy Rosen to Kidney Transplantation
This is a "connection" page, showing publications Amy Rosen has written about Kidney Transplantation.
Connection Strength
0.157
-
Ciancio G, Burke GW, Suzart K, Roth D, Kupin W, Rosen A, Gomez C, Mattiazzi A, Esquenazi V, Miller J. Effect of daclizumab, tacrolimus and mycophenolate mofetil in racial minority first renal transplant recipients. Transplant Proc. 2002 Aug; 34(5):1617-8.
Score: 0.042
-
Garcia-Morales RO, Ciancio G, Mathew J, Jin Y, Rosen A, Ricordi C, Burke GW, Blomberg B, Fuller L, Tzakis AG, Esquenazi V, Miller J. Perioperative donor bone marrow infusion in cadaver kidney transplant recipients. Transplant Proc. 2001 Nov-Dec; 33(7-8):3840-3.
Score: 0.040
-
Ciancio G, Miller A, Burke GW, Gharagozloo H, Rosen A, Roth D, Kupin W, Pinna A, Cespedes M, Esquenazi V, Miller J. Daclizumab induction for primary kidney transplant recipients using tacrolimus, mycophenolate mofetil, and steroids as maintenance immunosuppression. Transplant Proc. 2001 Feb-Mar; 33(1-2):1013-4.
Score: 0.038
-
Mathew JM, Garcia-Morales R, Fuller L, Rosen A, Ciancio G, Burke GW, Carreno M, Temple D, Tzakis AG, Ricordi C, Miller J, Esquenazi V. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses. Transplantation. 2000 Dec 27; 70(12):1675-82.
Score: 0.038